| 标题 |
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The lancet. Gastroenterology & hepatology 作者:Javle M; Roychowdhury S; Kelley RK; Sadeghi S; Macarulla T; et al 出版日期:2021/10/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)